PortfoliosLab logoPortfoliosLab logo
Natera, Inc. (NTRA)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US6323071042
CUSIP
632307104
IPO Date
Jul 2, 2015

Highlights

Market Cap
$27.34B
Enterprise Value
$26.55B
EPS (TTM)
-$1.52
Total Revenue (TTM)
$2.31B
Gross Profit (TTM)
$1.50B
EBITDA (TTM)
-$309.91M
Year Range
$125.38 - $256.36
Target Price
$251.88
ROA (TTM)
-8.68%
ROE (TTM)
-12.16%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Natera, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Natera, Inc. (NTRA) has returned -12.70% so far this year and 41.43% over the past 12 months. Looking at the last ten years, NTRA has achieved an annualized return of 35.51%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.


Natera, Inc.

1D
7.04%
1M
-3.87%
YTD
-12.70%
6M
24.24%
1Y
41.43%
3Y*
53.29%
5Y*
14.21%
10Y*
35.51%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Jul 2, 2015, NTRA's average daily return is +0.15%, while the average monthly return is +3.25%. At this rate, your investment would double in approximately 1.8 years.

Historically, 56% of months were positive and 44% were negative. The best month was Jun 2018 with a return of +61.4%, while the worst month was Mar 2022 at -38.1%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.

On a daily basis, NTRA closed higher 51% of trading days. The best single day was Mar 19, 2020 with a return of +40.0%, while the worst single day was Mar 9, 2022 at -32.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.89%-9.99%-3.87%-12.70%
202511.76%-12.06%-9.11%6.73%4.51%7.11%-20.88%25.88%-4.33%23.58%20.05%-4.07%44.72%
20245.27%31.16%5.75%1.55%14.70%1.65%-5.45%15.50%7.35%-4.72%38.71%-5.65%152.71%
20236.87%13.09%14.36%-8.65%-7.12%3.29%-7.07%29.88%-24.66%-10.80%41.75%11.96%55.94%
2022-24.35%-6.94%-38.13%-13.67%4.47%-3.41%32.62%4.81%-11.04%7.17%-12.44%-2.31%-56.99%
20217.15%8.86%-12.53%8.35%-14.43%20.60%0.87%3.41%-5.90%2.81%-20.17%2.11%-6.16%

Benchmark Metrics

Natera, Inc. has an annualized alpha of 24.99%, beta of 1.36, and R² of 0.16 versus S&P 500 Index. Calculated based on daily prices since July 06, 2015.

  • This stock captured 202.94% of S&P 500 Index gains and 142.34% of its losses — amplifying both gains and losses, but participating more in upside than downside.
  • R² of 0.16 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
24.99%
Beta
1.36
0.16
Upside Capture
202.94%
Downside Capture
142.34%

Return for Risk

Risk / Return Rank

NTRA ranks 69 for risk / return — better than 69% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


NTRA Risk / Return Rank: 6969
Overall Rank
NTRA Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
NTRA Sortino Ratio Rank: 6969
Sortino Ratio Rank
NTRA Omega Ratio Rank: 6666
Omega Ratio Rank
NTRA Calmar Ratio Rank: 6969
Calmar Ratio Rank
NTRA Martin Ratio Rank: 7070
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Natera, Inc. (NTRA) and compare them to a chosen benchmark (S&P 500 Index).


NTRABenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.00

0.90

+0.11

Sortino ratio

Return per unit of downside risk

1.58

1.39

+0.19

Omega ratio

Gain probability vs. loss probability

1.20

1.21

-0.01

Calmar ratio

Return relative to maximum drawdown

1.38

1.40

-0.02

Martin ratio

Return relative to average drawdown

3.73

6.61

-2.88

Explore NTRA risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Natera, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Natera, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Natera, Inc. was 77.74%, occurring on May 11, 2022. Recovery took 588 trading sessions.

The current Natera, Inc. drawdown is 21.39%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-77.74%Sep 20, 2021163May 11, 2022588Sep 13, 2024751
-70.93%Jul 6, 2015151Feb 8, 2016613Jul 16, 2018764
-60.84%Aug 27, 201893Jan 9, 2019146Aug 8, 2019239
-57.25%Nov 20, 201981Mar 18, 202035May 7, 2020116
-30.81%Feb 16, 202168May 21, 202182Sep 17, 2021150

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Natera, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Natera, Inc. is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for NTRA relative to other companies in the Diagnostics & Research industry. Currently, NTRA has a P/S ratio of 11.9. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for NTRA in comparison with other companies in the Diagnostics & Research industry. Currently, NTRA has a P/B value of 16.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items